Transcranial Magnetic Stimulation (TMS)
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
DESCRIPTION
- Repetitive transcranial magnetic stimulation (rTMS) utilizes a magnetic field applied noninvasively to the scalp to depolarize neurons in specific brain regions. It was first approved by the FDA for treatment of depression in 2008, specifically in patients with major depressive disorder who did not satisfactorily improve after one medication trial.
- Better tolerated than ECT, but not as efficacious[1].
-- To view the remaining sections of this topic, please log in or purchase a subscription --
DESCRIPTION
- Repetitive transcranial magnetic stimulation (rTMS) utilizes a magnetic field applied noninvasively to the scalp to depolarize neurons in specific brain regions. It was first approved by the FDA for treatment of depression in 2008, specifically in patients with major depressive disorder who did not satisfactorily improve after one medication trial.
- Better tolerated than ECT, but not as efficacious[1].
There's more to see -- the rest of this entry is available only to subscribers.